Given that development of thyroid autoimmunity and to a lesser extent T1DM, either separately or in combination, has been previously described after IFN-α treatment (14, , , –18), we hypothesized that activation of the type I IFN pathway may contribute to the pathogenesis of these organ-specific autoimmune disorders. This evidence concerns the gene IFNA1 and type 1 diabetes mellitus.